Adolescent cannabinoid exposure induces irritability-like behavior and cocaine cross-sensitization without affecting the escalation of cocaine self-administration in adulthood. by Kononoff, Jenni et al.
UC San Diego
UC San Diego Previously Published Works
Title
Adolescent cannabinoid exposure induces irritability-like behavior and cocaine cross-
sensitization without affecting the escalation of cocaine self-administration in adulthood.
Permalink
https://escholarship.org/uc/item/3fh5j955
Journal
Scientific reports, 8(1)
ISSN
2045-2322
Authors
Kononoff, Jenni
Melas, Philippe A
Kallupi, Marsida
et al.
Publication Date
2018-09-17
DOI
10.1038/s41598-018-31921-5
 
Peer reviewed
eScholarship.org Powered by the California Digital Library
University of California
1SCieNtifiC REPORTS |  (2018) 8:13893  | DOI:10.1038/s41598-018-31921-5
www.nature.com/scientificreports
Adolescent cannabinoid exposure 
induces irritability-like behavior 
and cocaine cross-sensitization 
without affecting the escalation 
of cocaine self-administration in 
adulthood
Jenni Kononoff  1, Philippe A. Melas2,3, Marsida Kallupi1, Giordano de Guglielmo1, 
Adam Kimbrough1, Maria Scherma4, Paola Fadda4,5, Denise B. Kandel6, Eric R. Kandel2,7 & 
Olivier George  1
Cannabis use is typically initiated during adolescence and is a significant risk factor for the development 
of cocaine use in adulthood. However, no preclinical studies have examined the effects of adolescent 
cannabinoid exposure on cocaine dependence in adulthood using the escalation model of cocaine self-
administration and the assessment of negative emotional states. In the present study, we found that 
exposure to the cannabinoid receptor agonist WIN55,212-2 (WIN) in adolescence produced irritability-
like behavior and psychomotor cross-sensitization to cocaine in adolescence. In adulthood, rats were 
allowed to self-administer cocaine. The acquisition of cocaine self-administration was lower in rats 
with adolescent WIN exposure compared with controls. However, both WIN-exposed and control 
rats escalated their cocaine intake at the same rate, had similar responding under a progressive-ratio 
schedule of reinforcement, and had similar psychomotor responses to cocaine. Interestingly, the 
increase in irritability-like behavior that was previously observed in adolescence after WIN exposure 
persisted into adulthood. Whether the persisting increase in irritability-like behavior after WIN exposure 
has translational relevance remains to be studied. In summary, these results suggest that psychoactive 
cannabinoid exposure during adolescence is unlikely to have a major effect on the escalation of cocaine 
intake or the development of compulsive-like responding per se in adulthood in a rat model of cocaine 
self-administration. However, whether the persisting irritability-like behavior may predispose an 
individual to mood-related impairments in adulthood or predict such impairments warrants further 
investigation.
Cannabis is one of the most frequently used psychoactive substances in the world1 and is the subject of major 
debates between proponents of the gateway hypothesis2 and advocates of legalization. Proponents of the gateway 
hypothesis have argued that epidemiological studies indicate that the early use of cannabis is an important risk 
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factor for initiating cocaine use, that cannabis dependence predicts cocaine dependence3–6, that cannabis use may 
be associated with poor cognitive and psychiatric outcomes in adulthood7–9, and that major changes in legaliza-
tion of the possession, sale, and cultivation of cannabis in the United States may exacerbate these poor outcomes 
by increasing the level of cannabis use in adolescents and young adults10. Cannabis use has been increasingly 
prevalent among adolescents and young adults. Currently, its use exceeds that of tobacco smoking among ado-
lescents in the United States, in which 37.1% of high school seniors in 2017 reported using cannabis within 
the past year11. Advocates of legalization and medicinal use argue that it is unclear whether the relationship 
between prior cannabis use and later cocaine use or cocaine use disorder is caused by cannabis use per se or 
other drug-associated factors, such as concomitant psychiatric disorders and socioeconomic status5,12. However, 
epidemiological studies cannot establish causal relationships between the pharmacological effects of exposure to 
cannabis and the development of cocaine use3,13.
Preclinical studies provide a controlled way to study causal relationships between early-life cannabinoid 
exposure and cocaine use, including compulsive-like use, later in life. Previous studies reported that exposure 
to the cannabinoid receptor agonist WIN55,212-2 (WIN) during adolescence decreased the reactivity of dopa-
minergic neurons to WIN (i.e., tolerance), produced cross-tolerance to cocaine in adolescence14, and produced 
cross-sensitization to the psychomotor effects of cocaine in adolescence but not in adulthood15. This effect 
appears to be mediated by the modulation of eukaryotic initiation factors in the brain15. Such modifications of 
key neural substrates may reprogram the adolescent brain and make it more susceptible to the later use of other 
illicit drugs, such as cocaine2,16. However, other groups found that prior treatment with either the main psycho-
active constituent of cannabis (Δ9- tetrahydrocannabinol [THC]) or WIN had no effect on behavioral responses 
to amphetamine in either adolescence or adulthood17. However, in the study by Ellgren et al.17, cannabinoid 
exposure lasted only 5 days, the doses of cannabinoid were low, and the animals were injected only once per day. 
A major limitation of these preclinical studies is the use of an animal model of cocaine exposure (psychomotor 
sensitization) that reflects neither the direct acquisition of cocaine use (measured by self-administration) nor the 
compulsive nature of cocaine use disorder (measured by the escalation of self-administration).
To address this issue, we tested the effect of adolescent exposure to the cannabinoid receptor agonist WIN 
on key addiction-related behaviors using a more complex animal model of drug addiction. The model included 
measures of irritability-like behavior, which has recently been used as a measure of the negative emotional state 
in animal models of addiction18–20. We also assessed cocaine-induced locomotion (i.e., cross-sensitization) in 
adolescence and adulthood and the acquisition of cocaine self-administration under conditions of short access 
(1 h) and long access (6 h; i.e., escalation of cocaine self-administration) in adulthood. The long-access model 
represents a comprehensive model of human addiction21 because it produces the escalation of cocaine intake that 
is associated with the emergence of negative emotional states22 and compulsive-like responding despite adverse 
consequence23–26.
Materials and Methods
Animals. Male Sprague-Dawley rats (Charles River, Wilmington, MA, USA; n = 18) were housed 2–3 per 
cage on a reverse 12 h/12 h light/dark cycle (lights off at 8:00 AM) in a temperature (20–22 °C)- and humid-
ity (45–55%)-controlled animal facility with ad libitum access to water and food. All of the experiments were 
designed to minimize animal suffering and the number of animals used. All of the procedures were conducted 
in adherence to the National Institutes of Health Guide for the Care and Use of Laboratory Animals and were 
approved by the Institutional Animal Care and Use Committee of The Scripps Research Institute. The rats were 
considered adolescent until postnatal day (PND) 6027.
Drugs. WIN55,212-2 mesylate (Tocris, Minneapolis, MN, USA) was dissolved in vehicle that contained 2% 
Tween 80, 2% ethanol, and saline and injected intraperitoneally (i.p.) in a volume of 1 ml/kg of body weight. 
Cocaine HCl (National Institute on Drug Abuse, Bethesda, MD, USA) was dissolved in 0.9% saline (Hospira, 
Lake Forest, IL, USA) at a dose of 0.5 mg/kg/0.1 ml infusion and self-administered intravenously.
Drug treatment. The experimental design of WIN exposure and behavioral testing during adolescence 
and later in adulthood is illustrated in Fig. 1. Prior to treatment, the rats were divided into two groups (n = 9/
group) that were matched for body weight and food and water intake. These parameters were also monitored 
Figure 1. Experimental design of WIN exposure and behavioral testing during adolescence and later in 
adulthood. LgA, long-access; PND, postnatal day; PR, progressive-ratio schedule of reinforcement; WIN, 
cannabinoid receptor agonist WIN55,212-2.
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throughout WIN treatment. The rats began treatment with WIN or vehicle during adolescence (PND42). Control 
rats received a corresponding volume of vehicle. Increasing doses of WIN (2 mg/kg, PND42-44; 4 mg/kg, PND45-
48; 8 mg/kg, PND49-52) or vehicle were administered twice daily for 11 consecutive days. The WIN dose regimen 
was chosen according to the literature for subchronic adolescent cannabinoid treatment28–30 and because it has 
been shown to induce psychomotor cross-sensitization to the effects of cocaine in adolescence15.
Irritability-like behavior. All behavioral testing was conducted during the dark phase. To test 
irritability-like behavior after WIN exposure, we used the bottle-brush test, based on the experimental method 
that was designed previously for mice31,32 and slightly modified to better monitor rat behavior19. Currently, this 
model is increasingly used by both our laboratory and others as a measure of negative emotional states in animal 
models of addiction18–20. This method has advantages over other behavioral paradigms that measure aggressive/
defensive behaviors, such as the social dominance/subordination paradigms and resident/intruder confrontation 
paradigm, because the experimenter has greater control over the mechanical stimulus and thus better precision 
in ensuring uniform provocation. Furthermore, the “social” factor in eliciting agonistic behavior and the risk of 
physical injury during an agonistic encounter are both circumvented in the bottle-brush test. The mechanical 
stimulus of the moving bottle-brush has also been found to be more effective in provoking these behaviors com-
pared with either deceased or stuffed animals32.
In the present study, the animals were randomized, and three trained observers scored the rats’ behaviors in 
real-time as described below. The observers were blinded to treatment of the animals. Testing consisted of ten 10-s 
trials with 10-s intertrial intervals in plastic cages (27 cm × 48 cm × 20 cm) with clean bedding. A bottle-brush 
was rotated rapidly toward the rat’s whiskers. Both aggressive responses (smelling, biting, boxing, following, and 
exploring the bottle-brush) and defensive responses (escaping, digging, jumping, climbing, defecation, vocali-
zation, and grooming) were recorded. The behavioral responses were chosen based on Riittinen et al. (1986)32 
and Lagerspetz and Portin (1968)33. Total aggressive and defensive scores were calculated for each animal based 
on the average score of the observers. Both aggressive and defensive behaviors were summed to calculate the 
total irritability score. Irritability-like behavior reflects a composite measure of aggressive vs. defensive responses. 
Irritability-like behavior was assessed 6 days after the last injection of WIN/vehicle in adolescence (PND58) and 
again in adulthood 18 h into withdrawal after the escalation of cocaine self-administration (PND123).
Cocaine sensitization. Locomotor stimulation by acute cocaine administration was assessed in rats with 
prior exposure to either vehicle or WIN. This test was performed in adolescence (PND60) to model the previ-
ous finding of WIN-induced cocaine cross-sensitization in adolescence15 and again in adulthood (PND130). 
After 30 min habituation to the acrylic experimental chamber (43.2 cm × 43.2 cm × 30.5 cm; Med Associates, St. 
Albans, VT, USA), the rats were injected with cocaine (10 mg/kg, i.p.), and locomotor activity was recorded for 
40 min under red light. Locomotor activity was recorded as the distance traveled (in centimeters) using a video 
camera that was connected to the ANY-maze Video Tracking System 5.11 (Wood Dale, IL, USA).
Intravenous catheterization. The rats were anesthetized by isoflurane inhalation, and intravenous cathe-
ters were aseptically inserted in the right jugular vein using a modified version of a procedure that was described 
previously33–35. The right jugular vein was punctured with a 22-gauge needle, and the tubing was inserted and 
secured inside the vein by tying the vein with suture thread. The catheter assembly consisted of an 18 cm length 
of MicroRenathane tubing (0.023 inch inner diameter, 0.037 inch outer diameter; Braintree Scientific, Braintree, 
MA, USA) that was attached to a guide cannula (Plastics One, Roanoke, VA, USA). The guide cannula was bent at 
a near right angle, embedded in dental acrylic, and anchored with a mesh (1 mm thick, 2 cm square). The catheter 
exited through a small incision on the back, and the base was sealed with a small plastic cap and metal cover cap. 
The catheters were flushed daily with heparinized saline (10 U/ml of heparin sodium; American Pharmaceutical 
Partners, Schaumburg, IL, USA) in 0.9% bacteriostatic sodium chloride (Hospira, Lake Forest, IL, USA) that 
contained 20 mg/0.2 ml of the antibiotic Cefazolin (Hospira, Lake Forest, IL, USA).
Operant training and escalation of cocaine self-administration in adulthood. Self-administration 
in adulthood was performed in operant conditioning chambers (Med Associates, St. Albans, VT, USA) that were 
enclosed in lit, sound-attenuating, ventilated environmental cubicles. The front door and back wall of the cham-
bers were constructed of transparent plastic, and the other walls were opaque metal. Each chamber was equipped 
with two retractable levers that were located on the front panel. Cocaine was delivered through plastic catheter 
tubing that was connected to an infusion pump, which was activated by responses on the right (active) lever. 
Responses on the left (inactive) lever were recorded but did not have any scheduled consequences. Activation of 
the pump resulted in the delivery of 0.1 ml of cocaine (0.5 mg/kg/0.1 ml). A computer controlled fluid delivery 
and behavioral data recording. The rats were first trained to self-administer cocaine under a fixed-ratio 1 (FR1) 
schedule of reinforcement in daily 1-h sessions. Each active lever press resulted in the delivery of one cocaine 
dose. A 20-s timeout (TO) period followed each cocaine infusion. During the TO period, responses on the active 
lever did not have scheduled consequences. This TO period occurred concurrently with illumination of a cue 
light that was located above the active lever to signal delivery of the positive reinforcement. The rats were trained 
to self-administer cocaine in 14 sessions (5 days/week) until a stable baseline of reinforcement was achieved 
(≤10% variation over the last three sessions). The criterion for the acquisition of cocaine self-administration was 
defined as the intake of at least 2.5 mg/kg cocaine in the 1-h self-administration session, requiring at least five 
lever presses. This criterion was adapted from previous publications36,37. After the 14-session acquisition period, 
the rats were subjected to fourteen 6-h cocaine self-administration sessions to allow them to escalate their cocaine 
intake22. To study the motivation to seek cocaine, a progressive-ratio (PR) schedule of reinforcement was used, in 
which the response requirement began at one lever press/infusion and increased exponentially according to the 
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following equation38: lever presses/infusion = [5 × e(infusion number × 0.2)] − 5. The session duration was limited to 6 h 
or ended when a rat failed to achieve the response requirement within 1 h. The PR sessions were conducted after 
the training/acquisition phase and again after a stable level of escalation was achieved. In the course of the exper-
iment, which lasted for more than 3 months, some rats were excluded at different stages of the experiment. Two 
rats (one in the control group and one in the WIN group) were excluded during the acquisition phase because of 
the failure of catheter patency. In the course of the escalation phase, three rats (one in the control group and two 
in the WIN group) were excluded from the study because of the failure of catheter patency at the end of the study, 
and one rat in the vehicle group died unexpectedly during the day off from cocaine self-administration before the 
study was completed, thus leaving n = 6 rats/group for the final analysis. The exclusion of those data did not affect 
the results of the statistical analysis.
Statistical analysis. The effects of WIN on body weight and cocaine self-administration were analyzed 
using two-way repeated-measures analysis of variance (ANOVA). Food and water intake during WIN expo-
sure, irritability-like behavior, 40-min cumulative scores for the cocaine challenge, and the PR data were 
analyzed using unpaired two-tailed Student’s t-test. The acquisition of cocaine self-administration was ana-
lyzed using Mantel-Cox survival analysis. Significant effects in the ANOVA were followed by Bonferroni’s 
multiple-comparison post hoc test. Values of p < 0.05 were considered statistically significant. The sample size 
(n = 6–9) was chosen based on a pre hoc power analysis (Power = 0.8, p < 0.05) to detect effect sizes (Cohen’s 
d = 1.3–1.6) that were similar to previously published effect sizes and demonstrated the effect of exposure to can-
nabinoid receptor agonists on cocaine sensitization (Cohen’s d = 1.6)15 and cocaine self-administration (Cohen’s 
d = 1.7)39. The sample size in the present study was also similar to previous studies that employed the escalation 
model of drug self-administration40–44. The level of intake in the present study was also comparable to previous 
studies that employed the escalation model of cocaine self-administration with larger sample sizes34,35,45.
Results
WIN decreases body weight and food intake but increases water intake in adolescence. During 
WIN treatment, body weight and food and water intake were monitored daily. A significant difference in the 
percentage of body weight gain was observed between WIN- and vehicle-treated rats (Fig. 2A). Weight gain in 
WIN-treated rats was lower than in vehicle-treated rats, confirmed by a significant interaction (F19,304 = 8.244, 
p < 0.0001) in the two-way repeated-measures ANOVA. The Bonferroni multiple-comparison post hoc analysis 
revealed that the weight gain difference between groups was significant on days 9–21 (p < 0.05 for day 9, p < 0.01 
for day 20, p < 0.001 for days 10 and 19, p < 0.0001 for days 11–18). WIN-treated rats also exhibited a reduction of 
average food intake during WIN treatment compared with controls, confirmed by Student’s two-tailed unpaired 
t-test (t20 = 4.647, p = 0.0002; Fig. 2B). Compared with controls, WIN-treated rats had significantly higher water 
intake during treatment (t20 = 4.794, p = 0.0001; Fig. 2C).
WIN induces irritability-like behavior and cross-sensitization to cocaine in adolescence. In 
adolescence, 6 days after the last WIN/vehicle treatment (PND58), rats that were treated with WIN exhibited 
an increase in irritability-like behavior compared with controls, measured by the total irritability score. This was 
analyzed by Student’s two-tailed unpaired t-test (t16 = 2.873, p = 0.0111; Fig. 3A). The effect-size and power anal-
yses also confirmed that adolescent WIN treatment increased irritability-like behavior in adolescence (Cohen’s 
d = 1.35, Power = 0.93 at a level of confidence of p < 0.05). The individual scores during adolescence for each 
recorded behavior are listed in Table 1.
On PND60, the rats were placed in the open field for 30 min of habituation, after which they were chal-
lenged with cocaine (10 mg/kg, i.p.), and locomotor activity was monitored for 40 min (Fig. 3B). The two-way 
Figure 2. (A) Chronic WIN treatment in adolescence decreased body weight. *p < 0.05, **p < 0.01, ***p < 0.001; 
#p < 0.0001 (two-way repeated-measures ANOVA followed by Bonferroni’s multiple-comparison post hoc test). 
(B) Chronic WIN treatment in adolescence decreased food intake. (C) Chronic WIN treatment in adolescence 
increased water intake. The data are expressed as mean ± SEM. ***p < 0.001 (Student’s unpaired two-tailed t-test; 
n = 9).
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repeated-measures ANOVA revealed significant effects of treatment (F1,16 = 10.57, p = 0.0050) and time 
(F6,96 = 35.71, p < 0.0001) but no treatment × time interaction (F6,96 = 0.5967, p = 0.7623). No significant dif-
ferences were found between groups in cumulative locomotor activity during 30-min habituation in adoles-
cence (t16 = 1.558, p = 0.1387). Rats with prior exposure to WIN exhibited an increase in activity during the 
cocaine challenge compared with controls, reflected by the 40-min cumulative locomotor activity score during 
the cocaine challenge (Fig. 3C). This was confirmed by Student’s two-tailed t-test (t16 = 2.655, p = 0.0173). The 
effect-size and power analyses also confirmed that adolescent WIN treatment increased locomotor activity during 
the cocaine challenge in adolescence (Cohen’s d = 1.23, Power = 0.90 at a level of confidence of p < 0.05).
WIN exposure in adolescence decreases the acquisition of cocaine self-administration but has no 
effect on escalation. Nineteen days after the last WIN treatment, the rats had reached adulthood and were 
trained to self-administer cocaine. Although there was a trend toward lower levels of cocaine self-administration 
during acquisition (1-h session) in WIN-exposed rats compared with controls, no significant difference was found 
between controls and WIN-treated rats, confirmed by the lack of an interaction in the two-way repeated-measures 
ANOVA (F13,182 = 0.7133, p = 0.7488, n = 8; Fig. 4A). A significant effect of time was observed (F13,182 = 0.6285, 
p < 0.0001), demonstrating an increase in self-administration, with no effect of treatment (F1,14 = 1.208, 
p = 0.2902). However, WIN-treated animals exhibited slower acquisition of cocaine self-administration com-
pared with controls. Only 50% of the WIN-treated rats acquired cocaine self-administration by day 9, whereas 
Figure 3. Irritability-like behavior and cocaine-induced cross-sensitization in adolescent rats. (A) Irritability-
like behavior increases after 6 days of abstinence from WIN. *p < 0.05 (Student’s two-tailed unpaired t-test). (B) 
WIN induces behavioral cross-sensitization to the psychostimulant effect of cocaine (10 mg/kg, i.p.). **p < 0.01, 
significant effect of treatment (two-way repeated-measures ANOVA). (C) The 40-min cumulative locomotor 
activity score during the cocaine challenge demonstrated that WIN-treated rats were more stimulated by 
cocaine. *p < 0.05 (Student’s two-tailed unpaired t-test; n = 9).
ADOLESCENCE ADULTHOOD
Control WIN df = 16 p Control WIN df = 10 p
Escape 8.4 ± 0.9 8.6 ± 0.6 t = 0.2 p = 0.8s4 7.4 ± 1.2 8.7 ± 0.4 t = 1.0 p = 0.34
Digging 0 ± 0 0.7 ± 0.4 t = 1.5 p = 0.16 0.1 ± 0.1 0.2 ± 0.2 t = 0.3 p = 0.79
Jumping 0.4 ± 0.3 0.5 ± 0.2 t = 0.3 p = 0.76 0.2 ± 0.2 0.0 ± 0.0 t = 1.0 p = 0.34
Climbing 3.4 ± 0.7 4.4 ± 0.5 t = 1.3 p = 0.21 4.5 ± 1.0 6.3 ± 0.4 t = 1.8 p = 0.10
Defecation 0.2 ± 0.1 1.3 ± 0.4 t = 2.8 *p = 0.01 0.2 ± 0.2 1.2 ± 0.5 t = 1.9 p = 0.09
Vocalization 0.1 ± 0.1 0.0 ± 0.0 t = 1.5 p = 0.15 0.1 ± 0.1 0.1 ± 0.1 t = 0.5 p = 0.66
Grooming 0.3 ± 0.1 0.7 ± 0.4 t = 0.8 p = 0.42 2 ± 0.9 0.7 ± 0.3 t = 1.4 p = 0.19
Smelling 1.1 ± 0.2 2.1 ± 0.5 t = 1.8 p = 0.09 1.4 ± 0.4 2.6 ± 0.7 t = 1.6 p = 0.14
Biting 0.2 ± 0.1 0.4 ± 0.2 t = 0.7 p = 0.52 0.0 ± 0.0 0.6 ± 0.5 t = 1.34 p = 0.24
Boxing 1.8 ± 0.4 1.5 ± 0.4 t = 0.5 p = 0.60 1.1 ± 0.7 1.7 ± 0.4 t = 0.8 p = 0.47
Following 1.2 ± 0.4 2.2 ± 0.6 t = 1.5 p = 0.18 2.4 ± 0.5 3.6 ± 0.7 t = 1.3 p = 0.21
Exploration 0.7 ± 0.2 1.4 ± 0.4 t = 1.7 p = 0.10 1.1 ± 0.4 1.7 ± 0.5 t = 1.0 p = 0.34
Total 17.8 ± 1.0 23.8 ± 1.9 t = 2.9 *p = 0.011 20.5 ± 1.9 27.3 ± 2.3 t = 2.3 *p = 0.048
Table 1. Individual irritability-like behaviors (mean ± SEM) during adolescence and adulthood after WIN 
exposure.
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100% of the control rats acquired cocaine self-administration by day 9. The acquisition criterion was a minimum 
of five lever presses (2.5 mg/kg cocaine) during the short-access session. The significant difference between groups 
was confirmed by Mantel-Cox survival analysis (log rank χ2 = 4.211, p = 0.0402; Fig. 4B). The motivation to 
self-administer cocaine at the end of the acquisition period (PND114), measured by PR responding, was unaltered 
by prior WIN treatment compared with controls (t14 = 0.482, p = 0.6372; Fig. 4C). During 14 long-access (6-h) ses-
sions of cocaine self-administration, both control rats and WIN-treated rats gradually escalated their cocaine intake. 
The two-way repeated-measures ANOVA confirmed a significant effect of time (F13,130 = 14.28, p < 0.0001) but no 
effect of treatment (F1,10 = 0.003261, p = 0.9556) and no treatment × time interaction (F13,130 = 0.5473, p = 0.7913). 
The one-way repeated-measures ANOVA, followed by Bonferroni’s multiple-comparison post hoc test, revealed 
the significant escalation of cocaine self-administration that started in the fifth 6-h session (p < 0.05 for session 5, 
p < 0.001 for sessions 6–8, p < 0.0001 for sessions 9–14). The two-tailed paired Student’s t-test indicated the same 
level of escalation in the first hour of the 6-h session (i.e., the loading phase) in control rats (t5 = 6.85, p = 0.0010) 
and WIN-treated rats (t5 = 5.474, p = 0.0028; Fig. 4E). Finally, adolescent WIN treatment had no effect on PR 
responding after the escalation of cocaine self-administration compared with controls (t10 = 0.018, p = 0.8608; 
Fig. 4F). The effect-size analysis showed that adolescent WIN treatment had no effect on cocaine escalation (Cohen’s 
d = 0.12), the loading-dose of cocaine self-administration (Cohen’s d = 0.22), or compulsive-like responding for 
cocaine before escalation (Cohen’s d = 0.24) or after escalation (Cohen’s d = 0.10), measured by PR responding.
WIN-induced irritability-like behavior but not cocaine cross-sensitization persists into 
adulthood. Irritability-like behavior was measured again in adulthood after the escalation of cocaine 
self-administration, 18 h into abstinence from cocaine. The calculated interobserver agreement demonstrated 
Figure 4. Cocaine self-administration in adulthood. (A) Cocaine self-administration on a fixed-ratio 1 (FR1) 
schedule during daily 1-h sessions (n = 8). (B) WIN treatment in adolescence decreased the acquisition of 
cocaine self-administration in adulthood. Acquisition was defined as the first session during which the rat 
consumed at least 2.5 mg/kg cocaine (five lever presses) in 1 h. *p < 0.05 (Mantel-Cox survival analysis). (C) 
Progressive-ratio (PR) responding for cocaine after short access was unaffected by prior WIN treatment. The 
data are expressed as the mean ± SEM number of rewards (left y-axis) or breakpoint (right y-axis; n = 8). (D) 
Prior WIN treatment had no effect on the escalation of cocaine intake during daily 6-h self-administration 
sessions. *p < 0.05, ***p < 0.001, ****p < 0.0001, significant difference from baseline (one-way repeated-
measures ANOVA followed by Bonferroni’s multiple-comparison post hoc test). (E) The first hour of the 6-h 
self-administration session (i.e., the loading phase) demonstrated the significant escalation of cocaine intake 
during 14 sessions compared with day 1 in both vehicle- and WIN-exposed rats. **p < 0.01 (Student’s two-tailed 
unpaired t-test). (F) Progressive-ratio (PR) responding for cocaine after long access (6 h) was unaffected by 
prior WIN treatment. The data are expressed as the mean ± SEM number of rewards (left y-axis) or breakpoint 
(right y-axis; n = 6).
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that the observers of behavior were in high agreement (r = 0.9350). In the control group, the baseline irrita-
bility score before cocaine self-administration was 17.8 ± 0.96 (mean ± SEM). After the escalation of cocaine 
self-administration, the irritability score was 20.5 ± 1.9, confirming that cocaine withdrawal per se did not affect 
irritability-like behavior. However, in rats with adolescent exposure to WIN, the increase in irritability-like behav-
ior persisted into adulthood (27.3 ± 2.3). The increase in the total irritability score was confirmed by Student’s 
two-tailed unpaired t-test (t10 = 2.253, p = 0.048; Fig. 5A). The effect-size and power analyses also confirmed that 
adolescent WIN treatment increased irritability-like behavior in adulthood (Cohen’s d = 1.42, Power = 0.89 at a 
level of confidence of p < 0.05). The individual scores for each recorded behavior during adulthood are listed in 
Table 1.
Six days after the last cocaine self-administration session, the rats were again placed in the open field for 
30 min of habituation, after which they were challenged with cocaine (10 mg/kg, i.p.), and locomotor activity was 
monitored for 40 min (Fig. 5B). The two-way repeated-measures ANOVA revealed a significant effect of time 
(F6,60 = 11.93, p < 0.0001) but no effect of treatment (F1,10 = 0.04206, p = 0.8416) and no treatment × time inter-
action (F6,60 = 1.82, p = 0.1103). No significant differences were found between groups in cumulative locomotor 
activity during 30-min habituation in adulthood (t10 = 0.9881, p = 0.3464). Rats with prior exposure to WIN 
exhibited no difference in 40-min cumulative locomotor activity scores during the cocaine challenge compared 
with control rats (t10 = 0.5659, p = 0.5839; Fig. 5C). The effect-size analysis also confirmed that adolescent WIN 
treatment had no effect on locomotor activity during the cocaine challenge in adulthood (Cohen’s d = 0.33).
At the end of the escalation phase, the mean ± SEM body weight was 432.5 ± 22.9 g in the control group and 
400.83 ± 29.4 g in the WIN group, demonstrating that the WIN-induced reduction of body weight during ado-
lescence recovered in adulthood.
Discussion
The present study found that adolescent WIN exposure (i) increased irritability-like behavior in adolescence, 
which persisted into adulthood, (ii) induced cross-sensitization to the locomotor-stimulating effect of cocaine 
in adolescence, which did not persist into adulthood, (iii) decreased the speed of acquisition but not the rate of 
cocaine self-administration in adulthood, and (iv) had no effect on the escalation of cocaine self-administration 
in adulthood. Overall, these results demonstrate that although cannabinoid exposure in adolescence induces 
irritability-like behavior and cross-sensitization to the psychostimulant effect of cocaine during adolescence, it 
does not promote cocaine self-administration once the animals reach adulthood. However, the effect of ado-
lescent WIN exposure on cocaine self-administration in adolescence was not investigated in the present study 
because the animals reached adulthood by the time they had recovered from the surgeries that were required for 
self-administration.
Reductions of both body weight and food intake were observed during WIN treatment. Although the acti-
vation of cannabinoid receptors typically produces an increase in food intake in adulthood46, accumulating evi-
dence suggests that adolescent exposure to THC or WIN in rats decreases food intake and body weight15,28,29,47. 
The increase in water intake during WIN exposure in the present study confirms the role of cannabinoid recep-
tors in homeostatic responses that regulate not only energy homeostasis but also fluid balance48.
Irritability, anxiety, and dysphoria are key negative emotional states that characterize the withdrawal syn-
drome in humans, which arises when access to the drug is prevented and contributes to drug relapse49. Irritability 
has also been reported to be greater in adolescents at higher risk for substance use50. Irritability-like behavior has 
also been shown to increase during withdrawal from alcohol and nicotine in rodents18–20. However, to our knowl-
edge, whether early exposure to cannabinoids affects irritability-like behavior has not been studied in animal 
models. In the present study, we found that WIN exposure induced irritability-like behavior in adolescence and 
Figure 5. Irritability-like behavior and cocaine-induced locomotor activity in adult rats. (A) Prior treatment 
with WIN increased irritability-like behavior 18 h after the last cocaine self-administration session. *p < 0.05 
(Student’s two-tailed unpaired t-test). (B) Prior WIN treatment did not alter cocaine-induced (10 mg/kg, i.p.) 
locomotor activity in adulthood. (C) The 40-min cumulative locomotor activity score during the cocaine 
challenge was unaffected by prior WIN treatment. n = 6.
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adulthood, suggesting that cannabinoid exposure in adolescence induces long-lasting neurobehavioral adapta-
tions that can persist months after WIN exposure. However, further studies are needed to investigate whether this 
finding has translational relevance. An alternative explanation is that, despite blind randomization of the subjects 
to the two groups, the increase in irritability-like behavior that was observed in WIN-treated rats may be attribut-
able to preexisting differences in irritability-like behavior. Further studies are needed to investigate whether this 
finding has translational relevance. Numerous human studies demonstrate that early cannabis use is associated 
with greater vulnerability to the later development of drug addiction and psychiatric illness51. A recent study 
reported a pivotal role for cannabinoid receptors as molecular mediators of adolescent behavior and suggested 
that cannabinoid receptors may be important in adolescent-onset mental health disorders52. Chronic adolescent 
exposure to WIN has also been shown to induce anxiety-like behavior in rats53. However, contradictory findings 
have also been published, with either no change54 or even a decrease55 in anxiety-like behavior after cannabinoid 
exposure in adolescence. Rats that were exposed to cannabis smoke were also reported to exhibit a decrease in 
anxiety-like behavior56. Interestingly, a previous study also demonstrated that long-term cognitive and behav-
ioral dysfunction that was induced by adolescent THC exposure could be prevented by concurrent cannabidiol 
treatment57. Importantly, WIN acts as a full cannabinoid receptor agonist, in contrast to THC, which only acts as 
a partial agonist. Moreover, cannabis is known to consist of dozens of additional phytocannabinoids apart from 
THC. Furthermore, different strains of cannabis differ in their THC content, and THC levels in cannabis have 
increased year after year because of consumer demand, thus making direct comparisons of human data across 
time and across studies difficult. Nevertheless, we chose this model of early cannabinoid exposure and followed it 
precisely because it has been shown to induce cocaine cross-sensitization, thus supporting the gateway hypothe-
sis15. Further studies are needed to investigate whether the long-term irritability-like behavior that was observed 
in the present study can be prevented by concurrent cannabidiol treatment or whether adolescent exposure to 
cannabis smoke induces long-lasting irritability-like behavior in rats.
Epidemiological data consistently document that cannabis exposure precedes the use of other illicit drugs6,12. 
However, epidemiological data cannot provide causal evidence of this sequence. Animal models are particu-
larly useful for studying effects that are related to cross-sensitization because they allow sequential adminis-
trations of the studied drugs while controlling for confounding variables. Several studies have reported 
behavioral cross-sensitization between cannabinoids and stimulants in rodents58–61. WIN treatment during 
adolescence in rats induces long-lasting cross-tolerance to morphine, cocaine, and amphetamine14, potentiates 
amphetamine-induced psychomotor sensitization62, and induces cocaine-induced psychomotor sensitization 
in adolescence15. WIN exposure also leads to increases in methylenedioxymethamphetamine-induced63 and 
cocaine-induced64 conditioned place preference. In the present study, WIN exposure in adolescence induced 
cross-sensitization to the stimulatory effect of cocaine in adolescence. However, this effect was no longer present 
in adulthood when the rats had self-administered cocaine for several weeks, suggesting that cannabinoid expo-
sure in adolescence may increase the psychomotor effects of cocaine during the first exposure to cocaine, but this 
effect is not necessarily long-lasting.
Cannabinoid exposure increased irritability-like behavior and the psychomotor effects of cocaine, but it 
did not promote the acquisition or escalation of cocaine self-administration. Indeed, we observed the slower 
acquisition of cocaine self-administration with 1-h short-access to cocaine in male rats with prior exposure 
to WIN compared with controls. In contrast, a previous study reported a trend toward an increase in cocaine 
self-administration during the short (7-day) acquisition phase (30-min session) in female rats with prior expo-
sure to the cannabinoid receptor agonist CP55,940 but not in male rats39. However, this study did not discrim-
inate between inactive and active levers, and no difference in cocaine self-administration was observed during 
the 14-day maintenance phase (2-h session) in either sex39. A recent study showed that adolescent WIN expo-
sure caused impairments in an attentional set-shifting task, a measure of cognitive flexibility, in adulthood 
(PND > 85)62. An alternative hypothesis is that the slower acquisition of cocaine self-administration in adult-
hood that was observed in the present study may be attributable to cognitive impairment that slows the acqui-
sition of operant responding. In humans, several studies have indicated that the adolescent use of cannabis can 
lead to long-term cognitive deficits, including problems with attention and memory65. During escalation, no 
differences were observed between the rats that were exposed to vehicle in adolescence and the rats that were 
exposed to WIN in adolescence. This suggests that if cognitive impairments affected the initial acquisition of 
self-administration, then they did not produce long-term deficits.
The model of long-access to cocaine self-administration is one of the most validated animal models of cocaine 
use disorder and drug addiction in general21,22,66. This model has been shown to result in all seven of the diag-
nostic criteria of the Diagnostic and Statistical Manual of Mental Disorders, 4th edition (DSM-IV), and seven of 
the 11 DSM-5 criteria, including most of the criteria that are required for severe use disorder: (i) tolerance67, 
(ii) withdrawal68,69, (iii) substance taken in larger amount than intended22, (iv) unsuccessful efforts to quit70,71, 
(v) considerable time spent to obtain the drug72, (vi) important social, work, or recreational activities given up 
because of use26,69,73, and (vii) continued use despite adverse consequences23–25,69,71,74,75. The present study found 
no effect of adolescent cannabinoid exposure in the escalation model, suggesting that adolescent WIN exposure 
may not facilitate the acquisition, maintenance, or escalation of cocaine use in adulthood. An alternative hypoth-
esis is that the effect of cannabinoid use may not be observed on cocaine intake per se; instead, cannabinoid expo-
sure may produce an increase in the motivation for cocaine, leading to an increase in compulsive cocaine seeking. 
Indeed, prior exposure to another potential gateway drug, alcohol, was found to have no effect on subsequent 
cocaine self-administration per se but produced greater motivation and compulsive-like cocaine seeking under 
a PR schedule of reinforcement76. However, we observed no differences between the WIN-exposed and control 
groups in adulthood when we used a PR schedule of reinforcement to examine whether rats with prior exposure 
to WIN express alterations of the motivation to self-administer cocaine.
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One limitation of long-term behavioral studies in adolescent rats, including the present study, is that 
puberty in rats is relatively short (~PND38-60 in males)27. Compared with adults, rats that are allowed to 
self-administer cocaine during adolescence (PND42-54) have been shown to be more vulnerable to cocaine 
addiction77. Unfortunately, in the model of cannabinoid exposure during adolescence (PND42-52), cocaine 
self-administration can only be studied starting in late adolescence and continuing into adulthood because rats 
exit puberty by PND6027. Because of this limitation, one possibility is that cannabinoid exposure during adoles-
cence may affect cocaine intake in adolescence.
The present results demonstrate that chronic exposure to cannabinoids does not facilitate the acquisition 
of cocaine self-administration or compulsive-like cocaine intake in adulthood, measured by the escalation of 
cocaine self-administration and PR responding in a relevant model of cocaine use disorder. These results suggest 
that cannabinoid exposure per se is unlikely to be causally responsible for the association between prior cannabis 
use and future cocaine use in adulthood as purported by the gateway hypothesis. However, we found that can-
nabinoid exposure produced long-lasting increases in irritability-like behavior, which may indirectly facilitate 
the emergence of social conflicts and other mental disorders that may contribute to the abuse of drugs other than 
cocaine. Additionally, the cross-sensitization between WIN and cocaine in adolescence—which was not observed 
in adulthood—may highlight a short-term increase in the vulnerability to cocaine-induced behaviors.
In summary, the present results showed that cannabinoid exposure during adolescence in rats produced 
cross-sensitization to cocaine in adolescence and a long-lasting increase in irritability-like behavior in adult-
hood. However, it did not facilitate the acquisition or escalation of cocaine self-administration or compulsive-like 
responding for cocaine in adulthood.
Data Availability
The datasets that were generated and analyzed in the present study are available from the corresponding author 
upon reasonable request.
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